The hormonal effect of fibroblast growth factor 19 on the intestinal adaptation in pediatric short bowel syndrome: an in vitro study using patients-derived enteroids
Topic overview
This study investigates how fibroblast growth factor 19 (FGF19) influences intestinal adaptation in pediatric short bowel syndrome using patient-derived enteroid models. The research aims to understand hormonal mechanisms that could enhance gastrointestinal recovery in children with SBS, potentially informing future therapeutic strategies.
Key takeaways
- FGF19 is a novel hormonal target for promoting intestinal adaptation in pediatric short bowel syndrome patients.
- Patient-derived enteroids provide a clinically relevant in vitro model to study intestinal adaptation mechanisms.
- Understanding FGF19's role may lead to new therapeutic strategies for restoring GI function in pediatric SBS.
- Hormonal modulation of intestinal adaptation represents an emerging approach beyond traditional nutritional support.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. The hormonal effect of fibroblast growth factor 19 on the intestinal adaptation in pediatric short bowel syndrome: an in vitro study using patients-derived enteroids. GlobalCastMD Medical Library. 2025-05-26. https://dev.library.globalcastmd.com/article/10494?via_space=staycurrentmd
Comments